University of Bonn
Bonn, North Rhine-Westphalia, 53105, Germany
NCT Number: NCT00883285
The purpose of this study is to compare the incidence of silent and apparent cerebral embolism between conventional and minimal-invasive transfemoral aortic valve repair.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Bonn, North Rhine-Westphalia, 53105, Germany
Patients undergoing aortic valve repair (AVR) are included prospectively into the study. AVR techniques include the conventional technique, the transfemoral and the transapical approach. Before the intervention CT of the chest is performed preoperatively to assess the degree of aortic and aortic valve calcification. Patients undergo MRI of the brain, including diffusion weighted imaging (DWI) and neurological assessment (NIHSS score) within 48 h before and after the procedure to assess occurrence of cerebral embolism.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 48 hours
Time frame: 48 hours
University Hospital, Bonn
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07492849
Atrophy, Brain Diseases
Kaohsiung City, Taiwan
View Trial DetailsNCT01796015
Brain Diseases, Cardiovascular Diseases
Bron, Auvergne-Rhône-Alpes, France
View Trial DetailsNCT03685578
Brain Diseases, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05767437
Brain Diseases, Cardiovascular Diseases
Ulsan, Ulju, South Korea
View Trial Details